Galvanize Theraputics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3200 Bridge Pkwy, Redwood City, Californ...Phone Number
(650) 268-4252Website
www.galvanizetx.comRevenue
$26.4 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Galvanize Theraputics
Galvanize aims to become the global leader in delivering medical technology innovations that drive biologic processes to treat a range of diseases, including solid tumors, and chronic bronchitis symptoms. The company is based in Redwood City, CA, and is developing and commercializing its revolutionary Aliya® PEF energy platform in the United States.Explore more
Galvanize Theraputics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Galvanize Theraputics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Galvanize Theraputics is spiking on competitors!
Check if Galvanize Theraputics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Galvanize Theraputics recently announced quarterly report
Product Launch: Get notified when Galvanize Theraputics launches new products
Congratulate Masked Content for being promoted to Masked Content at Galvanize Theraputics
Funding: Get notified immidiatlly once Galvanize Theraputics has new funding data
Galvanize Theraputics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Galvanize Theraputics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Galvanize Theraputics
Compare insights from companies similar to Galvanize Theraputics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Galvanize Theraputics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Galvanize Theraputics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Galvanize Theraputics.
Galvanize Theraputics financials insights
Gather financial insights about Galvanize Theraputics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series C
$100M
Stock/Share Issuance
$96.1M
Galvanize Theraputics Tech Stack
A closer look at the technologies used by Galvanize Theraputics
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Galvanize Theraputics has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Aliya. Areas of expertise include: Software Testing, Medical Device Manufacturing, Strategic Decision Making, Engineering Research, Biomedical Engineering, Anatomy, and Strategic Objectives.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Galvanize Theraputics News & Media
Galvanize Therapeutics Appoints Laura Francis to its Board of Directors
REDWOOD CITY, Calif., Nov. 24, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the appointment of Laura Francis to its...New Study Shows Aliya® Pulsed Electric Field Ablation Achieved Local Control of Lung Tumors in Metastatic Cancer Patients and May Induce an Immune Response
Six-month results from U.S. clinical study show promise for the innovative technology in patients with stage IV non-small cell lung cancer or lung metastasis REDWOOD CITY, Calif., Nov. 11, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical...Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease
Sofinnova Partners leads premier investor syndicate backing Galvanize's breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach targeting solid tumors and chronic bronchitis, the leading cause of COPD. REDWOOD CITY, Calif., Sept. 3, 2025 /PRNewswire/ --...Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung
REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed enrollment in the AFFINITY study evaluating Aliya PEF ablation in patients with stage IV non-small...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Galvanize Theraputics
Sign Up For FreeTo access detailed company insights
Galvanize aims to become the global leader in delivering medical technology innovations that drive biologic processes to treat a range of diseases, including solid tumors, and chronic bronchitis symptoms. The company is based in Redwood City, CA, and is developing and commercializing its revolutionary Aliya® PEF energy platform in the United States... Read More
